Citigroup
IMPV

Citigroup’s Imperva, Inc. IMPV Stock Holding History

Citigroup’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,600
Closed -$121K – 7939
2018
Q3 		$121K Buy
+2,600
New +$126K ﹤0.01% 5718
2018
Q2 		– Sell
-1,600
Closed -$69K – 7835
2018
Q1 		$69K Buy
1,600
+200
+14% +$8.98K ﹤0.01% 5934
2017
Q4 		$56K Sell
1,400
-43,900
-97% -$1.83M ﹤0.01% 6107
2017
Q3 		$1.97M Buy
45,300
+44,200
+4,018% +$2.02M ﹤0.01% 2680
2017
Q2 		$53K Buy
+1,100
New +$51.3K ﹤0.01% 5752

Citigroup's IMPV Position: Q1 2019 in Review

Citigroup sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 22,663 shares — an estimated $1.26M sold.

Citigroup first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $20.6M in Q2 2017. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Citigroup reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Citigroup sold 22,663 Imperva, Inc. shares in Q1 2019, an estimated $1.26M.
  • Citigroup first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
  • Citigroup's Imperva, Inc. position peaked at $20.6M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Citigroup's 13F filing for Q1 2019, filed 13 May 2019.